Login Register
icon_bulk_orderGroßauftrag Acrobiosystems for English
0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > Protein > Claudin-18.2 > CL2-H82E3

Biotinylated Human Claudin-18.2 Protein, His,Avitag™ (Detergent)

Empfohlene aktuelle Produkte:
SP-11 Streptavidin-beschichtete Platten, klar, 96-Well  STN-N5116 Rekombinantes Streptavidin  SMB-B01 Magnetische Beads™ Streptavidin 
Aufgrund der hohen Bindungsaffinität zwischen Biotin- und Streptavidin-Systemen werden unsere Produkte der Streptavidin-Serie zur Verwendung zusammen mit biotinylierten Proteinen empfohlen, um in kürzerer Zeit weniger unspezifische Bindungsergebnisse zu erzielen.
  • Synonym
    Claudin-18.2,CLDN18,Claudin-18
  • Source
    Biotinylated Human Claudin-18.2, His,Avitag(CL2-H82E3) is expressed from Baculovirus-Insect cells. It contains AA Met 1 - Ala 200 (Accession # P56856-2 ).
    Predicted N-terminus: Met
  • Molecular Characterization
    Claudin-18.2 Structure

    This protein carries an Avi tag at the N-terminus, followed by a polyhistidine tag. The protein has a calculated MW of 24.8 kDa.
    It is produced as active membrane protein with full ECD epitopes, and contains both the ECL1 and ECL2.

  • Labeling
    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.
  • Protein Ratio
    Passed as determined by the HABA assay / binding ELISA.
  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >60% as determined by SDS-PAGE.

  • Formulation

    This product is not suitable for cell based experiments due to cytotoxicity of DDM.
    DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumastance should you remove DDM and CHS.
    DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible to your application, remove glycerol just before immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, DDM, CHS, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped as sterile liquid solution with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
**The DDM/CHS buffer (Cat. No. DC-11) is sold separately and not included in protein, you can follow this link for product information.
Bioactivity-ELISA
 Claudin-18.2 ELISA

Immobilized Biotinylated Human Claudin-18.2, His,Avitag (Cat. No. CL2-H82E3) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 with a linear range of 0.1-2 ng/mL (in presence of DDM and CHS) (QC tested).

Bioactivity-SPR
 Claudin-18.2 SPR

Biotinylated Human Claudin-18.2, His,Avitag (Cat. No. CL2-H82E3) captured on Biotin CAP-Series S Sensor Chip can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 with an affinity constant of 4.74 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

  • Background
    Claudins (CLDNs) are a family of proteins that form tight junctions and maintain the polarity of epithelial and endothelial cells. CLDN18 is specifically expressed in the stomach and lung. Of the two CLDN18 isoform transcripts produced by alternative splicing, CLDN18.2 is a highly selective gastric lineage marker that determines the gastric phenotype in a neoplastic condition, whereas CLDN18.1 is lung specific. CLDN18.2 is a highly selective gastric lineage antigen expressed exclusively on short-lived differentiated gastric epithelial cells where it has only limited accessibility to antibody drugs.14,15 CLDN18.2 is maintained during the course of malignant transformation and thus frequently displayed on the surface of human gastric cancer cells.
  • Clinical and Translational Updates
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

Comments (0)


voraussichtlicher Versandzeitpunkt von vorrätigen Produkten: 2 Arbeitstage

Preis(EUR) : €1310.00

Preis(EUR) : €4220.00

Empfohlenes Top Produkt
Streptavidin-beschichtete Platte

Preis(EUR) : €30.00

Preis(EUR) : €140.00

Streptavidin-HRP

Preis(EUR) : €20.00

Preis(EUR) : €180.00

Magnetische Beads™ Streptavidin

Preis(EUR) : €210.00

Preis(EUR) : €350.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:24 Details
  • Latest Research Phase:Phase 3 Clinical

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Nachricht schicken